Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 1
Submit an article Journal homepage
143
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

PECAM is an effective and safe anthracycline-containing third-line regimen for patients with relapsed or refractory non-Hodgkin lymphoma

Fumi NakamuraDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
,
Honoka AraiDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
,
Katsuya TokitaDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
,
Shiho FuruichiDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
,
Fusako Sugita-NagasawaDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
,
Wataru TakahashiDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
,
Tomoyuki HandaDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
,
Hisako IsoDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
,
Jiro TadokoroDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
,
Shigeharu TsurumiDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
,
Yuko NakamuraDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
,
Yuka NakamuraDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
,
Ko SasakiDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
,
Sachiko SeoDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
,
Motoshi IchikawaDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
&
Kinuko MitaniDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, JapanCorrespondence[email protected]
 show all
Pages 239-242 | Received 09 Nov 2019, Accepted 23 Aug 2020, Published online: 11 Sep 2020
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

Dr. Seo reports personal fees from Janssen Pharmaceutical K.K., outside the submitted work.　 Dr. Ichikawa reports personal fees from Novartis Pharma, personal fees from Takeda Pharmaceutical, personal fees from Janssen Pharmaceutical, personal fees from Nippon Shinyaku, personal fees from Bristol-Myers Squibb, personal fees from Kyowa Kirin, outside the submitted work. Dr. Mitani reports grants from Kyowa Kirin, grants from Chugai, grants from Nihon Pharm., grants from Taiho, grants from MSD, grants from Daiichi-Sankyo, grants from Pfizer, from Astellas, grants from Takeda, grants from Teijin, grants from Sumitomo Dainippon, outside the submitted work.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.